SRGAP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.723400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.792000E-01
Normal-vs-Stage2
7.656400E-01
Normal-vs-Stage3
2.498800E-01
Normal-vs-Stage4
8.058000E-01
Stage1-vs-Stage2
8.802400E-01
Stage1-vs-Stage3
2.019800E-01
Stage1-vs-Stage4
9.767400E-01
Stage2-vs-Stage3
1.037350E-01
Stage2-vs-Stage4
9.293400E-01
Stage3-vs-Stage4
1.434600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.969000E-01
Normal-vs-AfricanAmerican
8.465400E-01
Normal-vs-Asian
3.426400E-01
Caucasian-vs-AfricanAmerican
9.903400E-01
Caucasian-vs-Asian
1.631980E-01
AfricanAmerican-vs-Asian
4.760200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.710200E-01
Normal-vs-Female
4.046400E-01
Male-vs-Female
2.749600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.856600E-01
Normal-vs-Age(41-60Yrs)
8.313400E-01
Normal-vs-Age(61-80Yrs)
4.852800E-01
Normal-vs-Age(81-100Yrs)
4.557600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.796400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.919400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.618800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.119910E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.427600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.127200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.002200E-01
Normal-vs-Daily Drinker
5.063200E-01
Normal-vs-Weekly Drinker
5.762600E-01
Normal-vs-Occasional Drinker
7.564400E-01
Normal-vs-Social Drinker
8.892400E-01
Non Drinker-vs-Daily Drinker
9.660800E-01
Non Drinker-vs-Weekly Drinker
8.295000E-01
Non Drinker-vs-Occasional Drinker
3.631800E-01
Non Drinker-vs-Social Drinker
3.159800E-01
Daily Drinker-vs-Weekly Drinker
8.597200E-01
Daily Drinker-vs-Occasional Drinker
3.896000E-01
Daily Drinker-vs-Social Drinker
3.299200E-01
Weekly Drinker-vs-Occasional Drinker
5.346600E-01
Weekly Drinker-vs-Social Drinker
4.484800E-01
Occasional Drinker-vs-Social Drinker
8.933400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.146400E-01
Normal-vs-Grade 2
2.360200E-01
Normal-vs-Grade 3
1.142030E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.200400E-01
Grade 1-vs-Grade 3
1.709040E-01
Grade 1-vs-Grade 4
5.146400E-01
Grade 2-vs-Grade 3
2.038600E-01
Grade 2-vs-Grade 4
2.360200E-01
Grade 3-vs-Grade 4
1.142030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.794600E-01
Normal-vs-NonDiabetic
5.562800E-01
Diabetic-vs-NonDiabetic
7.349400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.985400E-01
Normal-vs-NoPancreatitis
5.193400E-01
Pancreatitis-vs-NoPancreatitis
3.364800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.390600E-01
Normal-vs-N1
8.550000E-01
N0-vs-N1
1.833760E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.765800E-01
Normal-vs-TP53-NonMutant
9.033800E-01
TP53-Mutant-vs-TP53-NonMutant
7.255800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
